• 2419 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Medical Oncology

Training Experience

2001Residency, Dalhousie University, Canada
2004Fellowship, Univ. of Illinois Hospital

Education/Academic qualification

MD, McGill University

… → 1998

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Sarcoma Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2023

NADC Pilot

Agulnik, M., Roh, M. & Song, C.

National Cancer Institute


Project: Research project


Research Output 2001 2018

  • 2419 Citations
  • 49 Article
  • 25 Review article
  • 3 Comment/debate
  • 1 Short survey
17 Citations

Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)

Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 othersKing, A. D., Erlichman, C., Yin, J., Costello, B. A. & Chan, A. T. C., Jan 1 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.

Research output: Contribution to journalArticle

Multicenter Studies
Survival Rate
Disease-Free Survival
5 Citations

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

Rosenberg, A. & Agulnik, M., Apr 1 2018, In : Current treatment options in oncology. 19, 4, 19.

Research output: Contribution to journalComment/debate

Epithelioid Hemangioendothelioma
Clinical Trials

Growing Role of Regorafenib in the Treatment of Patients with Sarcoma

Agulnik, M. & Attia, S., Jun 21 2018, (Accepted/In press) In : Targeted Oncology. p. 1-6 6 p.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Synovial Sarcoma

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: A case report and review

Chae, Y. K., Chiec, L., Adney, S. K., Waitzman, J., Costa, R., Carneiro, B., Matsangou, M., Agulnik, M., Kopp, P. A. & Giles, F., Jun 15 2018, In : Oncotarget. 9, 46, p. 28281-28289 9 p.

Research output: Contribution to journalArticle

Posterior Leukoencephalopathy Syndrome
Takotsubo Cardiomyopathy
Thyroid Neoplasms
Protein-Tyrosine Kinases
Pharmaceutical Preparations
4 Citations

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Agulnik, M., Costa, R. L. B., Milhem, M., Rademaker, A. W., Prunder, B. C., Daniels, D., Rhodes, B. T., Humphreys, C., Abbinanti, S., Nye, L., Cehic, R., Polish, A., Vintilescu, C., McFarland, T., Skubitz, K., Robinson, S., Okuno, S. & Van Tine, B. A., Jan 1 2017, In : Annals of Oncology. 28, 1, p. 121-127 7 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Survival Rate
Vascular Endothelial Growth Factors
Confidence Intervals